Related Experiment Video
Updated: Oct 15, 2025
07:46
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
25.5K
The Renal Pathology of Obesity: Structure-Function Correlations
Nobuo Tsuboi1, Yusuke Okabayashi1
1Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Seminars in Nephrology
|October 30, 2021
Summary
Obesity can harm kidneys, leading to obesity-related glomerulopathy (ORG). This kidney disease involves glomerular hyperfiltration, a state confirmed by new research, contributing to kidney function decline.
Area of Science:
- Nephrology
- Pathology
- Obesity Medicine
Background:
- Obesity is a significant risk factor for kidney disease.
- Obesity-related glomerulopathy (ORG) is a biopsy-diagnosed kidney condition linked to obesity.
- Clinicopathologic studies offer insights into renal complications of obesity.
Purpose of the Study:
- To confirm the hypothesis of single-nephron glomerular hyperfiltration in ORG patients.
- To elucidate the mechanisms driving kidney damage in obesity-related glomerulopathy.
Main Methods:
- Utilized a combination of image analysis and biopsy-based stereology.
- Estimated single-nephron glomerular filtration rate in ORG patients.
- Detailed clinicopathologic observations.
Main Results:
- Confirmed single-nephron glomerular hyperfiltration as a key feature in ORG.
- Identified glomerulomegaly and focal segmental glomerulosclerosis in perihilar locations as typical histopathologic findings.
- Demonstrated overshooting in glomerulotubular and tubuloglomerular interactions.
Conclusions:
- Single-nephron glomerular hyperfiltration is a confirmed mechanism in ORG.
- This hyperfiltration contributes to podocyte damage, tubular overload, and tubulointerstitial scarring.
- A vicious cycle of nephron loss and kidney function impairment is established in ORG.
More Related Videos
Related Concept Videos
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
20
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
20
01:21External Anatomy of the Kidney
2.0K
The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
2.0K
01:24Obesity
716
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
716
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
17
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
17
01:21Drug Dosing: Obese Patients
16
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
16
01:20Pathophysiology of Diabetes
2.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.1K